[DOI] [PubMed] [Google Scholar] 9.Akalestou E, Miras AD, Rutter GA, le Roux CW
While the list of putative biomarkers continues to expand, it is becoming increasingly clear that there may be no single biomarker that can adequately meet the requirements of specificity and sensitivity, and that multiple biomarkers, in conjunction with clinical data, may offer better predictability (Dash et al., 2010)
Paper presented at British Pharmaceutical Conference, Newcastle upon Tyne September, 1980
2017 Feb 15;7(2):20
doi:10.3892/mmr.2015.4439 Join our mailing list Sign up to receive emails with information on health topics for teens and adults with Down syndrome, updates on research and education as well as information about upcoming events, classes and programs.
Thereby, likely, fewer lesions in BPC 157-therapy, is possibly a particular effect of pentadecapeptide BPC 157 itself on the endothelium integrity (long-ago demonstrated (39)) since acting as a novel mediator of Robert's cytoprotection in stomach that essentially maintains endothelium integrity (5, 9)
